PD-1 Inhibitor Therapy in a Patient with Preexisting P-ANCA Vasculitis: A Case Report and Review of the Literature

PD-1 Inhibitor Therapy in a Patient with Preexisting P-ANCA Vasculitis: A Case Report and Review of the Literature

Background. Recurrent endometrial cancer after definitive therapy is a lethal disease. Recently, immune checkpoint inhibitors (ICI) have improved the management of mismatch repair-deficient (MSI-H) endometrial cancer. Autoimmune side effects are known to occur with ICI. As a result, patients with pr...

Full description

Bibliographic Details
Main Authors:	Amanda Ramos, Marcela del Carmen, Oladapo Yeku
Format:	Article
Language:	English
Published:	Hindawi Limited 2020-01-01
Series:	Case Reports in Oncological Medicine
Online Access:	http://dx.doi.org/10.1155/2020/3428945

Similar Items

Biological therapy in the treatment of ANCA associated vasculitis
by: Smith, Rona Marie
Published: (2016)

Benzylthiouracil-induced ANCA-associated Vasculitis: A Case Report and Literature Review
by: Fatima Bensiradj, et al.
Published: (2019-12-01)

Immunopathogenesis of ANCA-Associated Vasculitis
by: Andreas Kronbichler, et al.
Published: (2020-10-01)

Epidemiology of ANCA associated vasculitis
by: Wenche Koldingsnes, et al.
Published: (2008-01-01)

ANCA-Associated Vasculitis: An Update
by: Salem Almaani, et al.
Published: (2021-04-01)

Methimazole-Induced ANCA Vasculitis: A Case Report
by: Precil Diego Miranda de Menezes Neves, et al.
Published: (2021-08-01)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
by: Zachary S. Wallace, et al.
Published: (2019-12-01)

ANCA-positive vasculitis: Clinical implications of ANCA types and titers
by: Vital Manuel Da Silva Domingues, et al.

Valvular involvement in ANCA-associated systemic vasculitis: a case report and literature review
by: Cohen Pascal, et al.
Published: (2011-02-01)

ANCA-associated vasculitis overlaps with systemic sclerosis: a case report and literature review
by: Rui Wu, et al.
Published: (2021-03-01)

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis
by: Frank B. Cortazar, et al.
Published: (2018-03-01)

Animal Models of ANCA Associated Vasculitis
by: Lani Shochet, et al.
Published: (2020-04-01)

Individualization of the ANCA associated vasculitis treatment
by: Zbigniew Zdrojewski
Published: (2014-09-01)

Treatment of Renal ANCA-associated Vasculitis
by: Mafalda Teixeira da Costa
Published: (2021)

Granulomatous Inflammation in ANCA-Associated Vasculitis
by: Antje Müller, et al.
Published: (2021-06-01)

p-ANCA-Associated Vasculitis Caused by Levamisole-Adulterated Cocaine: A Case Report
by: Michelle R. Carter, et al.
Published: (2013-01-01)

Case Report of Atypical Course of MPO-ANCA Associated Vasculitis
by: O.R. Boiarchuk, et al.
Published: (2014-11-01)

Is rituximab effective for induction of remission in ANCA-associated vasculitis?
by: Carmen Rain, et al.
Published: (2015-08-01)

Recommendations of the Brazilian Society of Rheumatology for the induction therapy of ANCA-associated vasculitis
by: Alexandre Wagner Silva de Souza, et al.

Rituximab induction therapy for de novo ANCA associated vasculitis in pregnancy: a case report
by: Claire Harris, et al.
Published: (2018-06-01)

Vasculitis p-ANCA positivo asociada al tratamiento con antileucotrienos
by: Beatriz García Pulido, et al.
Published: (2021-11-01)

Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis
by: Qiuyu Jin, et al.
Published: (2018-11-01)

Interstitial Lung Disease with ANCA-associated Vasculitis
by: Yasuhiro Katsumata, et al.
Published: (2015-01-01)

Interstitial Lung Disease with ANCA-associated Vasculitis
by: Yasuhiro Katsumata, et al.
Published: (2015-09-01)

ANCA-associated vasculitis in childhood: recent advances
by: Marta Calatroni, et al.
Published: (2017-05-01)

Why are patients with ANCA-associated vasculitis fatigued?
by: McClean, Andrew
Published: (2016)

Autoreactive B Cells in ANCA-Associated Vasculitis
by: Berti, Alvise
Published: (2021)

Adult-Onset ANCA-Associated Vasculitis in SAVI: Extension of the Phenotypic Spectrum, Case Report and Review of the Literature
by: Frederik Staels, et al.
Published: (2020-09-01)

The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells
by: Kai Werner, et al.
Published: (2019-12-01)

Reporte de un caso: Vasculitis asociada a ANCA P en el adulto mayor
by: Osvaldo Cardozo
Published: (2020-05-01)

A Rare Case of Digital Ischemia and Gangrene in ANCA-Associated Vasculitis with Review of the Literature
by: Richard A. Lau, et al.
Published: (2017-01-01)

CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1
by: Markus Zeisbrich, et al.
Published: (2021-05-01)

RECURRENT ANCA-ASSOCIATED VASCULITIS AFTER KIDNEY ALLOTRANSPLANTATION
by: N. F. Frolova, et al.
Published: (2016-03-01)

The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis
by: Sayo Takeda, et al.
Published: (2019-06-01)

Long- term outcome of paediatric patients with ANCA vasculitis
by: Pusey Charles D, et al.
Published: (2011-06-01)

Pathogenesis and Diagnosis of Otitis Media with ANCA-Associated Vasculitis
by: Naohiro Yoshida, et al.
Published: (2014-01-01)

Endothelial dysfunction of vessels at ANCA-associated systemic vasculitis
by: L. V. Sedaia, et al.
Published: (2015-08-01)

Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis
by: Rafeel Syed, et al.
Published: (2015-01-01)

GENETIC SUSCEPTIBILITY TO ANCA-ASSOCIATED VASCULITIS: STATE OF THE ART
by: Francesco eBonatti, et al.
Published: (2014-11-01)

Clinical features and outcomes of ANCA-associated renal vasculitis
by: Sidy Mohamed Seck, et al.
Published: (2012-01-01)